Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million
-
Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference
-
Body Energy Club Main Street Celebrates 6 Month Anniversary with Massive Community Appreciation Day
-
National Civil Rights Museum Reopens the Legacy Experience on May 16, Marking Its 35th Anniversary and 49 Days Before America’s 250th
-
Shopify Delivers Again as Merchants Clear $100 Billion in Q1 GMV
-
Atea Pharmaceuticals to Host First Quarter 2026 Financial Results and Business Update Conference Call on May 12, 2026
-
Sotera Health Announces Leadership Transition
-
EVgo Inc. Reports First Quarter 2026 Results with Record First Quarter Revenues
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Xali Gold Implements Baseline Studies for Drilling Permit Application at Pico Machay Gold Project in Peru
-
Editas Medicine Announces First Quarter 2026 Results and Business Updates
-
Autolus Therapeutics to Report First Quarter 2026 Financial Results and Host Conference Call on May 14, 2026
-
Colliers Reports First Quarter Results
-
Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW)
-
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
-
Presenting on Emerging Growth Conference 92 Day 1 on May 6; Register to live stream
-
Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
-
Mike Lindell Media Corp. - LindellTV (OTC:) MLMC Announces Another Milestone as Part of the Company Short-Term Goals Strategy by Adding Sentry H20
-
Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial
-
OTC Markets Group Welcomes CoTec Holdings Corp. to OTCQX
-
The Devon Group Names Kate Achille as Chief Executive Officer
-
Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
-
First Watch Restaurant Group, Inc. Reports Q1 2026 Financial Results
-
FactSet Increases Dividend
-
Relmada Therapeutics to Present NDV-01 Abstracts at AUA2026
-
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine
-
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
-
Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026
-
NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC PLC - Ordinary Shares
-
ANOTHER QUARTER OF STRONG MIX - 2026 GUIDANCE CONFIRMED
-
Morocco Strategic Closes Private Placement for a Total Amount of $7.5 Millions
-
Novo Nordisk A/S - share repurchase programme
-
BioNTech Announces First Quarter 2026 Financial Results and Corporate Update
-
Scorpio Tankers Inc. Announces Financial Results for the First Quarter of 2026, the Declaration of a Dividend and an Increase to its Securities Repurchase Program
-
TopBuild Reports First Quarter 2026 Results
-
Onity Group Announces First Quarter 2026 Results
-
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
-
First Abu Dhabi Bank Extends Collaboration with Temenos to Modernize Banking in Saudi Arabia
-
Income Protection Journal Features CDIA President Bob Herum in Disability Insurance Awareness Month Masterclass
-
Record Quarterly Lease Rent Revenue Reported in Willis Lease Finance Corporation’s First Quarter 2026 Financial Results
-
Seedli Capital Secures $20 Million from Nimbus Capital to Accelerate Global Exposure to Tokenized RWAs
-
FTC Solar Announces First Quarter 2026 Financial Results and Leadership Transition
-
G Mining Ventures Provides Q1 2026 Project Status Update on Oko West; Construction Advancing on Schedule and on Budget
-
Vivid Seats Reports First Quarter 2026 Results
-
Diagonal Therapeutics Expands Executive Leadership Team, Appoints Industry Veteran Jonathan Piazza as Chief Financial Officer
-
Planet 13 Appoints Nancy Saitta and Leilani Bradford to Board of Directors
-
Parsons Awarded Position on $2B Military Energy Resilience Program
-
embecta Announces Quarterly Cash Dividend
-
Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

